Moderator
Administrator
Member # 1
|
posted 18. July 2005 15:44
PNAS Early Edition April 12
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
Yu Liang, Maximilian Diehn, Nathan Watson , Andrew W. Bollen, Ken D. Aldape, M. Kelly Nicholas, Kathleen R. Lamborn, Mitchel S. Berger, David Botstein, Patrick O. Brown and Mark A. Israel
Abstract: Glioblastoma multiforme (GBM) is the most common form of malignant glioma, characterized by genetic instability, intratumoral histopathological variability, and unpredictable clinical behavior. We investigated global gene expression in surgical samples of brain tumors. Gene expression profiling revealed large differences between normal brain samples and tumor tissues and between GBMs and lower-grade oligodendroglial tumors. Extensive differences in gene expression were found among GBMs, particularly in genes involved in angiogenesis, immune cell infiltration, and extracellular matrix remodeling. We found that the gene expression patterns in paired specimens from the same GBM invariably were more closely related to each other than to any other tumor, even when the paired specimens had strikingly divergent histologies. Survival analyses revealed a set of ~70 genes more highly expressed in rapidly progressing tumors that stratified GBMs into two groups that differed by >4-fold in median duration of survival. We further investigated one gene from the group, FABP7, and confirmed its association with survival in two unrelated cohorts totaling 105 patients. Expression of FABP7 enhanced the motility of glioma-derived cells in vitro. Our analyses thus identify and validate a prognostic marker of both biologic and clinical significance and provide a series of putative markers for additional evaluation.
IP: Logged
|
Printer-friendly view of this topic